Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Danske Bank and SEB in relation to Raketech’s listing on Nasdaq First North Premier
Mandate

Vinge advises Danske Bank and SEB in relation to Raketech’s listing on Nasdaq First North Premier

June 20, 2018 Capital Markets and Public M&A

Vinge advises Danske Bank A/S, Danmark, Sverige Filial and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Raketech Group Holding plc – a marketing actor whose primary business involves using its online products to influence iGaming market users who are interested in sports and gambling and to guide them towards the best gambling services – on Nasdaq First North Premier. 

A prospectus was published on 18 June 2018 and the first day of trading on Nasdaq First North Premier is 29 June 2018. The total value of the offering amounts to between approx. SEK 530-550 million, assuming that the over-allotment option is exercised in full.
 
Vinge’s team consist mainly of David Andersson, Amanda Knutsson, Rikard Lindahl and Stephanie Stiernstedt.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025